Partnering Strategy

Anaphore intends to establish partnerships to utliize its Atrimer Technology Platform against disease targets of strategic interest. Anaphore also intends to collaborate on the drug candidates already progressing in the Anaphore pipeline. While the current focus of the pipeline is immunology and oncology, Anaphore has the ability collaborate on drug-development programs across different therapeutic categories.